logo
  • Home
  • About
    • Leadership
    • Scientific Advisors
    • Board
  • Science
    • Targeting the DDR
    • Clinical Trials
    • Pipeline
  • Investors & Partners
    • Our Investors
    • Our Partners
    • Merck KGaA
    • Novartis
  • Careers
    • Our Opportunities
    • Our Testimonials
    • Our Benefits
    • Core Values
  • News & Events
    • Press release
    • Media coverage
    • Conferences
  • Contact Us
artios header image

Press release

Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology

3 December 2020 | Press release

merck
Artios Pharma Strengthens Clinical Development Team with Senior Appointments

10 February 2020 | Press release

Article-3-400×400
Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor

6 November 2019 | Press release

Article-1-1-400×400
Artios Pharma appoints Tania Dimitrova as Chief Business Officer and expands presence in the United States

24 September 2019 | Press release

Tania1
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer

1 April 2019 | Press release

Ian
Artios Pharma Announces Appointment of Professor Rajesh Chopra as Non-Executive Director

11 February 2019 | Press release

Article-3-400×400
Artios Pharma Wins 2018 Lifestars EU Private Finance Raise of the Year Award

14 November 2018 | Press release

Screenshot 2022-03-01 at 09.17.55
Artios Pharma Announces $84 million (£65 million) Series B Financing

10 August 2018 | Press release

Article-6-400×400
Artios exercises option to in-license potential first-in-class nuclease development programme

8 March 2018 | Press release

Article-7-400×400
Artios Pharma Appoints Pierre Legault as Chairman of its Board of Directors

26 February 2018 | Press release

pierre
« Previous 1 2 3 Next »
logo

Quick Links

  • Homepage
  • About
  • Science
  • Our Investors
  • Our Partners
  • News & Events
  • Careers
  • Contact Us

Contact

UK Office: +44 (0)1223 867 900
General enquiries: info@artios.com
Careers: HR@artios.com
Finance: Accounts@artios.com

Our career opportunities

Our careers
© Artios Pharma 2022 | Website by Granite 5
Follow on twitter Follow on LinkedIn

Terms & conditions | Privacy policy | Site map

We use cookies to collect data, please see our privacy policy.